aVaxziPen

Abingdon, United Kingdom

aVaxziPen is focusing on next-generation vaccines for infectious diseases and emerging threat pathogens.

$1.6M raised

Jun 2023

Undisclosed

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has aVaxziPen raised?

aVaxziPen has raised $1.6M in total funding. The most recent round was Undisclosed. The last funding was announced in June 2023.

Who are aVaxziPen's investors?

aVaxziPen's investors include Coalition for Epidemic Preparedness Innovations.

Where is aVaxziPen headquartered?

aVaxziPen is headquartered in Abingdon, United Kingdom.

What does aVaxziPen do?

aVaxziPen is focusing on next-generation vaccines for infectious diseases and emerging threat pathogens.

What stage is aVaxziPen at?

aVaxziPen is at the Undisclosed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated June 6, 2023.

MLA

"aVaxziPen — Funding & Investors." VCBacked, June 6, 2023, https://www.vcbacked.co/company/avaxzipen. Accessed July 2, 2026.

APA

VCBacked. (2023). aVaxziPen — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/avaxzipen

Wikipedia (cite web)

{{cite web |title=aVaxziPen — Funding & Investors |url=https://www.vcbacked.co/company/avaxzipen |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated June 6, 2023.